Notice of Annual General Meeting of Vitrolife AB (publ) The

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Apr 1, 2014 at 5:15 AM

Notice of Annual General Meeting of Vitrolife AB (publ)

The Annual General Meeting of Vitrolife AB (publ) will take place on Monday May 5, 2014, at 5 p.m. in the company’s premises at Gustaf Werners gata 2 in Gothenburg. Notice of attendance at the Annual General Meeting shall be given no later than Monday, April 28, 2014, at 12 noon. Shareholders wishing to participate at the Annual General Meeting shall notify the company by mail to Vitrolife AB (publ), Box 9080, SE-400 92 Gothenburg, Sweden, Att: Anita Ahlqvist, by phone +46 31 721 80 83, by fax +46 31 721 80 99 or by e-mail aahlqvist@vitrolife.com. Full name/business name, personal identification number/ company registration number (or the equivalent), address, telephone number, number of shares, details of any advisors and where appropriate details of a representative or proxy must be stated in the notification. A proxy form in Swedish for shareholders wishing to be represented by proxy will be found on www.vitrolife.com. Shareholders that have their shares registered in the name of a nominee must temporarily record their shares in the share register kept by Euroclear Sweden AB in their own names to be able to attend the General Meeting. Such registration must be carried out no later than Monday, April 28, 2014. The following proposals will be amongst those presented at the Annual General Meeting: · Dividend of SEK 1.00 per share and Thursday, May 8, 2014, as the record date for the dividend. · The Election Committee proposes that the number of members of the Board of Directors shall be six. Fredrik Mattsson, Maris Hartmanis, Tord Lendau, Barbro Fridén, Carsten Browall and Pia Marions are proposed for re-election as Board members. It is proposed that Carsten Browall is re-elected as Chairman of the Board. · Remuneration to the Board of Directors is proposed to be a total of SEK 1,110,000, of which SEK 330,000 is to be allocated to the Chairman of the Board, SEK 150,000 to each of the other Board members and SEK 30,000 to the Chairman of the Audit Committee. The proposal equals an increase of the total remuneration to the Board of SEK 210,000. · Authorization for the Board to resolve to issue new shares up until the next Annual General Meeting. · Authorization for the Board to make a decision on the acquisition of the company’s own shares during the period up until the next Annual General Meeting. Attachment: Full notice Gothenburg, April 1, 2014 VITROLIFE AB (publ) The Board Contact: Carsten Browall, Chairman of the Board, phone +46 70-255 65 32 Mikael Engblom, CFO, phone +46 31 721 80 14 Vitrolife is required to publish the information in this press release in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on April 1, 2014 at 11.00 a.m. This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails. ________________________________________________________________________________ _ ________________________________ Vitrolife (http://www.vitrolife.com/en/Corporate/) is an international medical device Group. Vitrolife Fertility (http://www.vitrolife.com/en/Fertility/) product area develops, produces and markets medical devices for assisted reproduction. Work is also carried out to enable the use and handling of stem cells for therapeutic purposes Vitrolife (http://www.vitrolife.com/en/Corporate/) has approximately 240 employees and the company's products are sold in almost 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in USA, Australia, France, Italy, United Kingdom, China, Japan, Hungary and Denmark. The Vitrolife share (http://www.vitrolife.com/en/Corporate/Financial/The-share1/) is listed on NASDAQ OMX Stockholm (http://www.nasdaqomxnordic.com/aktier/shareinformation?Instrument=SSE 1 3469), Small Cap. ________________________________________________________________________________ _ ________________________________ Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail: info@vitrolife.com. Website: www.vitrolife.com/

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

U Power's H1 2026: Inside the Financial Numbers

Financial Struggles Amid Expansion Efforts Imagine a ship trying to lift anchor while taking on water. That's U Power Limited's latest financials for the first half of 2026 in a nutshell. We're seeing the company, listed under NASDAQ: UCAR, navigating through turbulent financial seas while executing ambitious expansion projects. Revenue Declines Spell Trouble Total net...

Pigeon Unveils Green Innovations at CIIE 2026

An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...

Tenax Therapeutics Faces Legal Heat After Stock Plunge

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

ALMIA's Bold Medicare Defense to HHS Committee

ALMIA Lays It Out for Medicare Stakeholders The folks at ALMIA are shaking things up, and they're not pulling any punches with the HHS Healthcare Advisory Committee. With this latest move, they've lobbed public comments towards the committee, especially ahead of this intense November 9th meeting. It's part of a larger dialogue kicked off with the Strengthening Medicare...

Pen Needles Market to Hit $3.37B by 2031: Growth Ahead

Big Numbers in the Needle Game When you're staring down the numbers popping out of this pen needles market projection, it's hard to ignore—shooting from a respectable $2.16 billion in 2026 to a hefty $3.37 billion by 2031. We're talking a 9.3% CAGR that'll have investors pulling out their calculators or maybe rubbing their hands in downright glee, depending on their...

IBM's Quantum Leap in Chicago Puts Illinois on Map

Chicago Steps into the Quantum Race In a world where cutting-edge tech isn't just desired, it's demanded, Chicago's just put itself on the quantum map with IBM's latest move. The unveiling of IBM Quantum System Two at the University of Chicago marks a milestone not just for the city, but for Illinois at large. This isn't some pie-in-the-sky tech dream—it's a tangible...

Investor Bidding on Off-Market Homes Surges 35% Higher

Investor Frenzy in Off-Market Real Estate Looking at the real estate puzzle today, one might spot an unexpected surge in enthusiasm for off-market residential properties. We've got iFinder Offers, a real estate platform that's made it its business to connect the dots between homeowners and a gaggle of over 325 hungry investors. And according to their magic spreadsheets,...

Illinois Greenlights Major Water Utility Merger

Regulators Signal Green Light for Major Merger When was the last time a deal didn't hit some bumps in the regulatory road? This time, American Water and Essential Utilities are keeping the wheels greased, with the Illinois Commerce Commission giving their merger proposal a thumbs up. It feels like a classic case of utilities sticking to their market playbook—get bigger...

Encore Boston Harbor Workers Triumph After 62-Day Strike

Labor Standoff at Encore Boston Harbor Ends After a stormy 62 days on the picket lines, around 1,300 workers at Encore Boston Harbor finally find themselves back at their posts, carrying with them the spoils of hard-fought victory. This isn't just a paper contract; it's a banner for worker solidarity. These aren't your run-of-the-mill stock flips, folks; this fight was...

TELUS Targets Debt Reduction Amid Telecom Transformation

Adjusting Strategy Amid Financial Challenges The market's a tough beast, and TELUS seems to be wrestling with it, showing both grit and foresight in its latest quarterly update. Third quarter 2026 has TELUS down on revenues with a notable net loss but don't count them out yet. Their Transformation Strategy is a gamble worth watching. Where the Numbers Stand Here's the...